Green Thumb Industries (GTBIF) Deferred Taxes (2019 - 2022)
Green Thumb Industries (GTBIF) posted Deferred Taxes of -$17.5 million for Q4 2022, down 34.65% on a QoQ basis from -$13.0 million in Q4 2021, and down 34.65% year-over-year from -$26.7 million in Q4 2021.
Green Thumb Industries (GTBIF) Deferred Taxes (2019 - 2022) Analysis & Trends
Green Thumb Industries' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$17.5 million for Q4 2022.
- Quarterly Deferred Taxes fell 34.65% year-over-year to -$17.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$23.3 million (down 388.81% YoY) and the FY2025 annual result came in at $144.5 million, up 3018.11% from the prior year.
- Deferred Taxes was -$17.5 million for Q4 2022 at Green Thumb Industries, down from -$13.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $7.2 million in Q3 2021 and bottomed at -$17.5 million in Q4 2022.
- A 4-year average of -$2.6 million and a median of -$648000.0 in 2021 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2020 — Deferred Taxes sank 1866.67% — and 2021, when it surged 498.58%.
- Green Thumb Industries' Deferred Taxes stood at -$8.0 million in 2019, then surged by 71.36% to -$2.3 million in 2020, then tumbled by 468.8% to -$13.0 million in 2021, then slumped by 34.65% to -$17.5 million in 2022.
- Business Quant data shows GTBIF's Deferred Taxes at -$17.5 million in Q4 2022, -$13.0 million in Q4 2021, and $7.2 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | 25.90 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.60 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.49 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | - |
| 10 | Green Thumb Industries | 1.64 Bn | 1.30 Bn | 143.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -17.48 Mn |
| Dec 31, 2021 | -12.98 Mn |
| Sep 30, 2021 | 7.18 Mn |
| Jun 30, 2021 | -648,000.00 |
| Mar 31, 2021 | 1.69 Mn |
| Dec 31, 2020 | -2.28 Mn |
| Sep 30, 2020 | 4.97 Mn |
| Jun 30, 2020 | -169,000.00 |
| Mar 31, 2020 | -424,000.00 |
| Dec 31, 2019 | -7.97 Mn |
| Sep 30, 2019 | -1.58 Mn |
| Jun 30, 2019 | -4.16 Mn |
| Mar 31, 2019 | 24,000.00 |